Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Raltegravir 400mg tablets
0503010AEAAAAAA
|
Raltegravir | Raltegravir | Infections | 9 |
|
Raltegravir 600mg tablets
0503010AEAAAEAE
|
Raltegravir | Raltegravir | Infections | 1 |
|
Isentress 100mg chewable tablets
0503010AEBBABAB
|
Isentress | Raltegravir | Infections | No data available |
|
Isentress 100mg granules for oral suspension sachets
0503010AEBBADAD
|
Isentress | Raltegravir | Infections | No data available |
|
Isentress 25mg chewable tablets
0503010AEBBACAC
|
Isentress | Raltegravir | Infections | No data available |
|
Isentress 400mg tablets
0503010AEBBAAAA
|
Isentress | Raltegravir | Infections | No data available |
|
Isentress 600mg tablets
0503010AEBBAEAE
|
Isentress | Raltegravir | Infections | No data available |
|
Raltegravir 100mg chewable tablets
0503010AEAAABAB
|
Raltegravir | Raltegravir | Infections | No data available |
|
Raltegravir 100mg granules for oral suspension sachets
0503010AEAAADAD
|
Raltegravir | Raltegravir | Infections | No data available |
|
Raltegravir 25mg chewable tablets
0503010AEAAACAC
|
Raltegravir | Raltegravir | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.